Brief: CNS Pharma Completes U.S. Manufacturing Of Berubicin For Phase 2 Trial

CNS Pharmaceuticals

20/10/2020 13:05

Oct 20 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS COMPLETES U.S. MANUFACTURING OF
BERUBICIN
FOR PHASE 2 CLINICAL TRIAL
    * CNS PHARMACEUTICALS INC - LOOK FORWARD TO INITIATING A
U.S.
PHASE 2 TRIAL FOR BERUBICIN DURING Q1 OF 2021

Source text for Eikon:  ID:nPn3Gcg8Da 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))